- Home
- FUNC vs BDTX Comparison
FUNC vs BDTX Comparison
Compare FUNC & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUNC | BDTX |
|---|---|---|
| Founded | 1900 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.5M | 220.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FUNC | BDTX |
|---|---|---|
| Price | $40.01 | $2.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 27.6K | ★ 1.7M |
| Earning Date | 02-04-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | ★ 56.67 | N/A |
| EPS | ★ 3.84 | 0.38 |
| Revenue | ★ $83,662,000.00 | $70,000,000.00 |
| Revenue This Year | $16.22 | N/A |
| Revenue Next Year | $7.42 | N/A |
| P/E Ratio | $10.49 | ★ $6.72 |
| Revenue Growth | ★ 17.79 | N/A |
| 52 Week Low | $24.66 | $1.20 |
| 52 Week High | $42.50 | $4.94 |
Technical Indicators
Market Signals| Indicator | FUNC | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 27.63 |
| Support Level | $40.39 | $2.61 |
| Resistance Level | $41.56 | $2.72 |
| Average True Range (ATR) | 0.65 | 0.25 |
| MACD | 0.09 | -0.03 |
| Stochastic Oscillator | 50.83 | 18.30 |
Price Performance
Historical ComparisonAbout FUNC First United Corporation
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.